Practical AI for CEOs


The AI race is on. CEOs recognise it as the new force multiplier. AI has the potential to both reshape productivity and drive commercial effectiveness. This report by Criticaleye Partner AlixPartners provides a guide to help manage an array of competing stakeholder demands and develop your understanding and capabilities.
 
Key Takeaways Include:
  • Your data is one of your most valuable assets - make it work for you.
  • A fear of missing out and a herd mentality can disproportionately influence technology investments in the current market, potentially leading to poor returns.
  • Deep experience in dealing with business problems, combined with AI insights, drives the kind of actionable results that customers demand.

Share this with your Community





Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

Women Leaders in an AI Era: Navigating Opportunity and Change

AI has swiftly become a defining force in business life, reshaping how organisations operate, compete and grow. This report by AlixPartners explores how women in senior leadership are responding to business disruption, ...


Click here to download this insight

2027 Data Center Market Outlook

The data centre industry is heading into 2027 facing mounting technology disruption, financial distress and a wave of deal activity. This report by AlixPartners surveys the views of more than 480 senior executives,...


Click here to download this insight

Stream Impact Report 2025

Financial wellbeing is becoming an increasingly important issue for employers, with financial stress having a direct impact on employees’ lives, productivity and resilience. This report by Stream explores the...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 234




NATS Lightsource bp Hitachi Solutions Global Payments Rolls-Royce British Land Drax Group plc Legal & General London Stock Exchange Group E.ON UK LACE Partners AlixPartners Stream GlaxoSmithKline plc Mayborn Group NatWest Group